FDA Inspection 1232973 — Kaiser Permanente Of The Mid-Atlantic States IRB #7

Kaiser Permanente Of The Mid-Atlantic States IRB #7 — FEI 3013826200

The FDA completed an inspection of Kaiser Permanente Of The Mid-Atlantic States IRB #7 on Feb 26, 2024 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 26, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rockville, MD (United States)

Additional Details

IRB